Association Between Dose Dialysis by Kt and Mortality

Evaluation of the Association of Dialysis Dose Obtained by Kt and Mortality in Hemodialysis Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01932853

Enrollment

6129

Registered

2013-08-30

Start date

2013-10-31

Completion date

2015-12-31

Last updated

2016-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease, Hemodialysis Patients

Brief summary

The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* \> 18 years old * \> six months on hemodialysis * Receiving 3 sessions of dialysis per week * Having 5 or more valid measures of Kt during the month

Exclusion criteria

* active chronic inflammatory diseases * Liver cirrhosis * Neoplasms * Chronic immunosuppression or use of anti-inflammatory

Design outcomes

Primary

Measure	Time frame
Mortality	two years

Secondary

Measure	Time frame
Hospitalization	two years

Other

Measure	Time frame
Mortality and hospitalization cause	two years

Countries

Spain

Outcome results